Annual Cash & Cash Equivalents
$39.88 M
-$5.40 M-11.92%
December 31, 2023
Summary
- As of February 22, 2025, ACRS annual cash & cash equivalents is $39.88 million, with the most recent change of -$5.40 million (-11.92%) on December 31, 2023.
- During the last 3 years, ACRS annual cash & cash equivalents has risen by +$17.82 million (+80.75%).
- ACRS annual cash & cash equivalents is now -30.06% below its all-time high of $57.02 million, reached on December 31, 2018.
Performance
ACRS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$47.65 M
+$24.82 M+108.68%
September 30, 2024
Summary
- As of February 22, 2025, ACRS quarterly cash and cash equivalents is $47.65 million, with the most recent change of +$24.82 million (+108.68%) on September 30, 2024.
- Over the past year, ACRS quarterly cash and cash equivalents has increased by +$8.61 million (+22.06%).
- ACRS quarterly cash and cash equivalents is now -58.00% below its all-time high of $113.45 million, reached on June 30, 2021.
Performance
ACRS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ACRS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.9% | +22.1% |
| 3 y3 years | +80.8% | -11.1% |
| 5 y5 years | -30.1% | +59.4% |
ACRS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.9% | +45.8% | -30.2% | +108.7% |
| 5 y | 5-year | -11.9% | +80.8% | -58.0% | +116.0% |
| alltime | all time | -30.1% | +315.9% | -58.0% | +383.7% |
Aclaris Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $47.65 M(+108.7%) |
| Jun 2024 | - | $22.83 M(-36.3%) |
| Mar 2024 | - | $35.84 M(-10.1%) |
| Dec 2023 | $39.88 M(-11.9%) | $39.88 M(+2.1%) |
| Sep 2023 | - | $39.04 M(+25.3%) |
| Jun 2023 | - | $31.15 M(-30.3%) |
| Mar 2023 | - | $44.72 M(-1.2%) |
| Dec 2022 | $45.28 M(+65.6%) | $45.28 M(-26.6%) |
| Sep 2022 | - | $61.65 M(-9.7%) |
| Jun 2022 | - | $68.26 M(+87.8%) |
| Mar 2022 | - | $36.34 M(+32.9%) |
| Dec 2021 | $27.35 M(+24.0%) | $27.35 M(-49.0%) |
| Sep 2021 | - | $53.60 M(-52.8%) |
| Jun 2021 | - | $113.45 M(+221.7%) |
| Mar 2021 | - | $35.27 M(+59.8%) |
| Dec 2020 | $22.06 M(-35.5%) | $22.06 M(-6.7%) |
| Sep 2020 | - | $23.64 M(-27.4%) |
| Jun 2020 | - | $32.59 M(-39.6%) |
| Mar 2020 | - | $53.99 M(+57.9%) |
| Dec 2019 | $34.19 M | $34.19 M(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $29.90 M(-5.5%) |
| Jun 2019 | - | $31.65 M(-7.4%) |
| Mar 2019 | - | $34.20 M(-40.0%) |
| Dec 2018 | $57.02 M(+182.2%) | $57.02 M(+114.4%) |
| Sep 2018 | - | $26.59 M(-42.2%) |
| Jun 2018 | - | $46.03 M(-16.1%) |
| Mar 2018 | - | $54.88 M(+171.7%) |
| Dec 2017 | $20.20 M(-33.0%) | $20.20 M(-66.4%) |
| Sep 2017 | - | $60.05 M(+83.6%) |
| Jun 2017 | - | $32.71 M(+38.1%) |
| Mar 2017 | - | $23.68 M(-21.5%) |
| Dec 2016 | $30.17 M(+206.3%) | $30.17 M(+69.5%) |
| Sep 2016 | - | $17.80 M(-44.1%) |
| Jun 2016 | - | $31.82 M(+142.3%) |
| Mar 2016 | - | $13.13 M(+33.3%) |
| Dec 2015 | $9.85 M(-8.4%) | $9.85 M(-61.2%) |
| Sep 2015 | - | $25.42 M(+158.0%) |
| Jun 2015 | - | $9.85 M(-8.4%) |
| Dec 2014 | $10.76 M(+12.2%) | $10.76 M |
| Dec 2013 | $9.59 M | - |
FAQ
- What is Aclaris Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual cash & cash equivalents year-on-year change?
- What is Aclaris Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Aclaris Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ACRS is $39.88 M
What is the all time high annual cash & cash equivalents for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual cash & cash equivalents is $57.02 M
What is Aclaris Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ACRS annual cash & cash equivalents has changed by -$5.40 M (-11.92%)
What is Aclaris Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ACRS is $47.65 M
What is the all time high quarterly cash and cash equivalents for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly cash and cash equivalents is $113.45 M
What is Aclaris Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ACRS quarterly cash and cash equivalents has changed by +$8.61 M (+22.06%)